Related Experiment Video
Updated: Mar 2, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Anticoagulation after Atrial Fibrillation Ablation: Many Blanks to Fill
1Department of Cardiology, Heart Centre, Hospital Podlesí a.s., Třinec, Czech Republic.
Insights
Maintaining sinus rhythm after atrial fibrillation ablation is crucial but challenging to confirm long-term. Continuous monitoring is difficult, impacting decisions about discontinuing anticoagulation therapy.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Long-term maintenance of sinus rhythm (SR) after catheter ablation for atrial fibrillation (AF) remains an unresolved clinical question.
- Decisions regarding anticoagulation cessation post-ablation depend on the assumption of sustained SR and absence of asymptomatic AF.
- Current follow-up methods have limitations in detecting subclinical arrhythmias and ensuring continuous monitoring.
Purpose of the Study:
- To address the open issue of long-term SR maintenance post-atrial fibrillation ablation.
- To highlight the importance of confirming persistent SR for anticoagulation management.
- To discuss the challenges in monitoring asymptomatic patients for AF recurrence.
Main Methods:
- The abstract does not specify methods, focusing on the clinical dilemma.
- Discussion revolves around the limitations of current ECG monitoring tools.
- Routine follow-up practices are mentioned as potentially inadequate.
Main Results:
- The abstract does not present specific results.
- It emphasizes the difficulty in ascertaining the absence of asymptomatic AF episodes.
- It notes the challenges in applying continuous ECG monitoring tools.
Conclusions:
- Long-term SR maintenance after AF ablation requires further investigation and data.
- Accurate and continuous monitoring is essential for informed clinical decisions.
- The current follow-up strategies may not be sufficient for all patients.
Abstract:
Long-term maintenance of sinus rhythm (SR) after catheter ablation of atrial fibrillation (AF) has remained an open issue awaiting further relevant data. It is of paramount importance as our everyday decisions on discontinuing anticoagulation after ablation rest on the belief in the absence of clinically significant asymptomatic AF episodes and constant SR for the rest of the patient's life. Both aspects are difficult to ascertain, for the tools of truly continuous ECG monitoring are not comfortably applicable, and routine follow-up tends to thin out beyond 1 year in asymptomatic patients without apparent arrhythmia recurrences.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemodialysis I: Introduction

